# Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome

> **NCT05726019** · PHASE2 · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 100 (actual)

## Conditions studied

- Coronary Artery Disease
- Acute Coronary Syndrome
- Coronary Artery Bypass
- Myocardial Reperfusion
- Postpericardiotomy Syndrome
- Postoperative Atrial Fibrilation
- Perioperative Myocardial Infarction

## Interventions

- **DRUG:** Colchicine

## Key facts

- **NCT ID:** NCT05726019
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-05
- **Primary completion:** 2025-12-21
- **Final completion:** 2025-12-21
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05726019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05726019, "Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05726019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*